BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Embryo
,
Avian flu virus
,
Valproic acid
,
rs3825942
,
SLC12A1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
negative regulation of dermatome development
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Breast tissue
Bronchus
Stomach fundus
Duodenum
Lymph nodes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Williams syndrome
Hypercalciuria
Anomaly of chromosome pair 7
Bronchitis
Syndrome of infant of diabetic mother
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Clobetasol
Glial Cell Line-Derived Neurotrophic Factor
Tolazamide
Betamethasone
Cardiotoxin I
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MEF2B
ANKS6
DIS3L2
TSC2
LGI1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Transcriptional profiling of embryonic thymus tissue and fibroblast cells from Dnmt3b mutant mice
Gene expression in ectopic and eutopic endometrium
Rapamycin-insensitive up-regulation of MMP2 and other genes in TSC2- deficient LAM-like cells
Gene expression changes in the lungs of idiopatic pulmonary fibrosis patients
Microvascular endothelial HMEC-1 cells treated with bleomycin or cisplatin
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for negative regulation of dermatome development
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)
Ketogenic Diet to Improve Neuro-recovery
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ